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ABSTRACT 
Bioassay-guided fractionation of the leaves of Macaranga barteri collected from Nigeria led 
to the isolation of three previously undescribed cytotoxic stilbenes, macabartebenes A-C (1-3), 
together with six known compounds including prenylated stilbenes: vedelianin (4), 
schweinfurthin G (5), and mappain (7), prenylated flavonols: 8-prenylkaempferol (6), and 
broussoflavonol F (8), and the geranylated flavonol, isomacarangin (9). The cytotoxicity of the 
compounds was evaluated against four human cancer cell lines, with vinblastine as the positive 
control and DMSO vehicle as the negative control. Vedelianin (IC50 = 0.32 – 0.54 μM) 
displayed the greatest antiproliferative activity across the panel of cancer cell lines amongst the 
compounds, while macabartebene A (IC50 = 0.60 – 0.79 μM) was the most potent of the 
previously unreported compounds. The compounds displayed varying selectivity towards the 
cancer cell lines compared to the normal human prostate cell line. The findings of this study 
revealed that M. barteri leaves contain several cytotoxic compounds. 
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A549, human lung adenocarcinoma; ANOVA, one-way analysis of variance; ATCC, American 
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correlated spectroscopy; DCM, dichloromethane; DEPTQ, distortionless enhancement by 
polarisation transfer; DMSO, dimethyl sulfoxide; ECACC, European collection of 
authenticated cell cultures; FBS, foetal bovine serum; FHI, forest herbarium Ibadan; HeLa, 
human cervix adenocarcinoma; HMBC, heteronuclear multiple bond correlation; HPLC, high 
performance liquid chromatography; HR-EI-MS, high resolution electrospray ionization mass 
spectrometry; HSQC, homonuclear single quantum correlation; Hz, hertz; IC50; 50% inhibitory 
concentration; IR, infrared spectroscopy; MCF7, human breast adenocarcinoma; MeOH, 
methanol; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium; m/z, mass to charge 
ratio; n-hex, n-hexane; NOESY, nuclear Overhauser effect spectroscopy; NCI, national cancer 
institute; NMR, nuclear magnetic resonance; OD, optical density; PBS, phosphate buffered-
saline; PC3, human prostate adenocarcinoma; PNT2, normal human immortalised prostate cell 
line; SEM, standard error of mean; SI, selectivity index; SS, stock solution; TFA, 
trifluoroacetic acid; UV, ultraviolet spectroscopy; VLC, vacuum liquid chromatography; 
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1. Introduction 
     The genus Macaranga, comprising over 300 species, is one of the largest genera of the 
family Euphorbiaceae and the only genus in the subtribe Macaranginae. These plants are native 
to South-East Asia, West Africa and the South Pacific region [1]. Plants in this genus are used 
in folklore medicine for the treatment of boils, cancer, cough, cuts, diarrhoea, hypertension, 
stomach-ache, swellings and wounds [2-6]. Only about 10% of the plants in this genus have 
been investigated for their phytochemical constituents and biological activities. Previous 
phytochemical studies revealed that this genus produces prenylated and geranylated 
flavonoids, stilbenes, tannins, terpenes, chalcones, coumarins and steroids [7,8]. Several 
publications from the Laboratory of Drug Discovery Research and Development of the 
National Cancer Institute have reported the presence of several potent cytotoxic molecules in 
some members of this genus, especially M. schweinfurthii [9-12]. 
     In our search for novel cytotoxic compounds from Nigerian plants, we discovered that the 
extract of the leaves of M. barteri Mull. Arg. displayed potent antiproliferative activity against 
rhabdomyosarcoma cell line [13,14]. Macaranga barteri (synonym; M. heudelotii A. Chev.), 
called ‘Agbasa’ or ‘Aarasa’ by the Yoruba people of southwestern Nigeria is one of the few 
members of the Macaranga genus available in southwestern Nigeria. Traditional healers in 
Cameroon, Equatorial Guinea, Ghana, Ivory Coast, Liberia, Nigeria and Sierra Leone utilise 
the barks and leaves of the plant for the treatment of several ailments including anaemia, 
bronchitis, cough, fever, gonorrhoea and vermifuge [15,16]. A recent research revealed that the 
essential oils of the leaves of M. barteri contain many constituents that include eremophilene, 
6-epi-shyobunol and methyl salicylate. Other minor constituents of the oils of this plant include 
β-eudesmene, allo-aromadendrene and dihydro-β-agarofuran [17]. Previous  phytochemical 
studies focused on the stem bark of M. barteri afforded several bioactive compounds including 
macabarterin, ellagic acid, gallic acid and scopoletin [18].  
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     The present paper describes the bioassay-guided isolation, structure elucidation and 
antiproliferative activity of three new stilbenes, macabartebenes A-C and six other known 
compounds (Fig. 1). 
 
2. Materials and methods 
2.1. General experimental procedures 
     UV spectra were recorded on an Analytik Jena UV Visible spectrophotometer (Germany) 
with MeOH as a solvent. IR spectra were recorded on a PerkinElmer FTIR Spectrum BX 
spectrometer. 1D and 2D NMR spectra were recorded in CD3OD using residual solvents as the 
internal standard on a Bruker Avance III Spectrometer at 600 MHz for 1H NMR and 150 MHz 
for 13C NMR, respectively. Quaternary, methine, methylene and methyl carbons were 
differentiated by DEPT experiments. COSY experiment was used to determine 1H 
homonuclear connectivities. HSQC experiment was used to determine 1H-13C one-bond 
connectivities experiment while HMBC experiment was used to determine two and three bond 
connectivities. The chemical shift values (δ) are reported in parts per million (ppm), and the 
coupling constants value (J) are measured in Hertz (Hz). High resolution mass spectrometric 
data (HRESIMS) were measured using the Thermo Scientific LTQ Orbitrap XL mass 
spectrometer at the EPSRC UK National Mass Spectrometry Facility (Swansea, Wales). Solid 
phase extraction (SPE) was performed on a Strata C-18 cartridge (35µm; 70Å; 20 g). HPLC 
purification was performed on an Agilent 1260 infinity HPLC System coupled with an Agilent 
1260 diode array detector using an Ace-5 C18 column (150 × 21.2 mm, 5 µm particle size, 
Hichrom Ltd). HPLC grade solvents were purchased from Fischer Scientific (Loughborough, 
UK). Absorbance measurement for the MTT assay were taken on a CLARIOstar microplate 
reader (BMG labtech, Germany). Cell culture materials including Dulbecco’s Modified Eagle 
Medium (DMEM), foetal bovine serum (FBS) and trypsin were obtained from Biosera 
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(Nauaille, France). Chemicals including 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
(MTT), vinblastine, trypan blue, phosphate buffered-saline (PBS) tablets and penicillin-
streptomycin antibiotics suspension were purchased from Sigma-Aldrich (Dorset, UK). 
 
 
2.2. Plant material 
     The leaves of Macaranga barteri Mull. Arg. (Euphorbiaceae) were collected in Ibadan, 
southwestern Nigeria, in June 2016. The plant material was identified and authenticated at 
Forest Herbarium Unit (FHI), Forestry Research Institute of Nigeria, Ibadan, Nigeria. Voucher 
specimens (FHI 110626) have been deposited at the FHI. 
 
2.3. Extraction and Isolation 
     Air-dried and powdered leaves of M. barteri (190 g each) were Soxhlet-extracted, 
sequentially, with n-hexane, dichloromethane (DCM) and methanol (MeOH), 800 mL each. 
To ensure exhaustive extraction, ten cycles were allowed for each extraction, and the heating 
mantle was kept constant at 50 °C for all extraction. Filtered extracts were dried using a rotary 
evaporator at 40 °C and stored in the refrigerator prior to use. To facilitate the isolation of the 
cytotoxic constituents of the DCM extract, it was needful to remove the rich chlorophyll 
pigment present in the DCM extract. This was achieved by a solid phase extraction (SPE) of 
this fraction. A Strata C-18 cartridge (35 µm; 70 Å; 20 g) was washed with MeOH (50 mL) 
followed by equilibration with HPLC grade water (100 mL). The dried DCM fraction (2 g x 2) 
was dissolved in MeOH (10 mL x 2) and allowed to run through the activated cartridge. The 
eluate, which was mainly free of the chlorophyll pigment, was dried to give the purified DCM 
extract (2.91 g). A portion of the purified DCM extract (2 g) was fractionated using SPE. 
Briefly, 2 g of the purified DCM fraction was dissolved in 10 mL of 20% MeOH-H2O solution 
and loaded on to the activated cartridge [19]. The cartridge was eluted with a binary gradient 
7 
 
solvent system to obtain seven fractions: 20, 40, 60, 70, 80, 90 and 100% MeOH in water 
(200 mL each), coded respectively as MBF1, MBF2, MBF3, MBF4, MBF5, MBF6 and MBF7. 
All seven fractions were evaporated to dryness and stored in the refrigerator prior to cytotoxic 
screening. Of these, MBF4 and MBF5, which were the most active against the cancer cell lines, 
were further purified as described below. Each time, UV detection was at 220, 254, and 320 
nm, the flow rate was maintained at 10 mL/min. In addition, the injection volume and 
concentration were maintained at 300 µL and ca. 5 mg/mL, respectively. MBF5 (231 mg) was 
purified on reverse-phase preparative HPLC (mobile phase: H2O/MeOH containing 0.1 
trifluoroacetic acid (TFA); 0-5 min: 30-85% MeOH, 5-25 min: 80-95% MeOH, 25-30 min: 95-
100% MeOH, 30-35 min: 100% MeOH, 35-40 min: 30% MeOH) to afford 1 (13.2 mg; tR = 
8.2 min), 2 (5.7 mg; tR = 8.9 min), 3 (5.5 mg; tR = 11.7 min), 4 (5.1 mg; tR = 15.1 min) and 5 
(7.7 mg; tR = 18.1 min). MBF4 (191 mg) was purified on reversed phase preparative HPLC 
(mobile phase: H2O/ACN containing 0.1 trifluoroacetic acid (TFA); 0-4 min: 30-75% ACN, 
5-25 min: 75-95% ACN, 25-30 min: 95-100% ACN, 30-35 min: 100% ACN, 35-40 min: 30% 
ACN) to afford 6 (5.7 mg; tR = 12.3 min), 7 (6.3 mg; tR = 13.1 min), 8 (4.9 mg; tR = 14.7 min) 
and 9 (16.1 mg; tR = 17.2 min). 
 
2.3.1. Macabartebene A (1) 
     Amorphous, yellow powder; UV (MeOH) λmax (log ε) 332 (1.50) nm; IR (KBr) νmax3341, 
2648, 2161, 1587, 1513, 1432, 1064, 1041 cm-1; 1H and 13C NMR data, see Table 1; positive 
HRESIMS m/z 467.2788 [M+H]+ (calcd for C29H39O5, 467.2792). 
 
2.3.2. Macabartebene B (2) 
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     Amorphous, pale yellow powder; UV (MeOH) λmax (log ε) 330 (0.91) nm; IR (KBr) 
νmax3347, 2323, 1587, 1513, 1436, 1064, 1041 cm-1; 1H and 13C NMR data, see Table 1; 
positive HRESIMS m/z 467.2789 [M+H]+ (calcd for C29H39O5, 467.2792). 
2.3.3 Macabartebene C (3) 
     Amorphous, brown powder; UV (MeOH) λmax (log ε) 202 (2.94), 332 (1.65) nm; IR (KBr) 
νmax3325, 2161, 1587, 1513, 1437, 1064, 1041 cm-1; 1H and 13C NMR data, see Table 1; 
positive HRESIMS m/z 467.2788 [M+H]+ (calcd for C29H39O5, 467.2792). 
 
2.4. Cell lines and cell culture 
     Human adenocarcinoma cell lines: breast (MCF7), cervix (HeLa), lung (A549) and prostate 
(PC3) were purchased from American Type Culture Collection (ATCC), (LGC Standards, 
Middlesex, UK) and the normal human immortalised prostate cell line (PNT2) was obtained 
from the European Collection of Authenticated cell cultures (ECACC), (Public Health 
England, Salisbury, UK). The cells were cultured in T75 flasks containing DMEM medium 
supplemented with 10% FBS and 1% penicillin-streptomycin antibiotics suspension. The cells 
were maintained in a humidified atmosphere containing 5% CO2 at 37 °C and passaged bi-
weekly at a 1:3 dilution using 0.05% trypsin - 0.02% EDTA in PBS. Visual investigation of 
cells was made using an inverted microscope (Olympus CKX41, UK) at magnifications of 40x 
and 100x. Cells were counted using an automated haemocytometer (C-Chip NanoEnTek, 
USA). 
 
2.5. Cytotoxicity assay 
     After repeated initial experiments, the cell densities for optimal growth were found to be 
2000, 4000, 1200, 2000 and 4000 cells/well for MCF-7, HeLa, A549, PC3 and PNT2 
respectively. The cell lines were seeded into all wells in a 24 well plate (Corning® Costar® 
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TC-treated, Merck, UK) and incubated at 37°C/5% CO2 overnight to allow the cells to adhere 
to the surface of the plate. After 24 h, the old medium was removed by aspiration, and serial 
dilutions of extracts/compounds (1 mL each) in DMSO, positive control vinblastine in DMSO 
or vehicle control (DMSO) were added to quadruplicate wells, and the microtiter plates were 
incubated for a further 72 h. All dilutions of stock solutions of the extracts/compounds, 
vinblastine positive control and the DMSO vehicle control were made in cell culture media 
with the final concentration of DMSO of 0.1%, which had previously been found not to be 
cytotoxic [19]. At the expiration of the treatment period, the MTT assay was performed to 
measure the cell viability. The protocol described by Mossman [20] in 1983 was adopted with 
slight modifications. Briefly, the old medium was removed from each well by aspiration and 
replaced with 1 mL of 500 µg/mL MTT dye in medium. The plates were incubated for 2 h at 
37°C/5% CO2 to allow the production of formazan crystals. After incubation, the medium was 
removed by aspiration and 500 µL of propanol to each well was added to dissolve the dark blue 
formazan crystals. The plates were placed on a shaker for 10 min to enhance the dissolution of 
preformed formazan crystals. The dilution in each 24-well plate was transferred into a 96-
microtitre plate and the absorbance of the solution was measured at 570 nm on a Clario Star 
microplate reader. The average absorbance reading obtained from the negative control wells 
was set arbitrarily at 100% and the average absorbance readings of treatment wells was 
calculated as percentage relative to the negative control. In addition, the same process was 
carried out for vinblastine (positive control) using the concentration range mentioned above. 
Each experiment was carried out in quadruplicate on three different occasion and the cell 
viability was calculated as (A-B) / A, where A and B is the absorbance value of the control and 
the treated cells, respectively [21]. The IC50 (concentration required for the reduction of cell 
viability by 50%) was estimated using the Microsoft Excel version 2016 from dose−response 
curves obtained from three independent experiments. The results obtained were expressed as 
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mean ± standard errors of means (SEM). Statistical analysis was done using GraphPad (Version 
5.01, GraphPad Prism Software Inc., San Diego, CA,). One-way analysis of variance 
(ANOVA) followed by Tukey’s test (each treatment compared to control) were used to test for 
the statistical differences between the groups. Differences between means were considered 
statistically significant when P < 0.05. To obtain the selectivity index (SI) of the isolated 
compounds, the PNT2 cell line was used. The SI value was calculated as the ratio of the IC50 
values of the compounds on PNT2 cells relative to those in the cancer cell lines [22].   
 
3. Results and discussion 
     Macabartebene A (1) was obtained as a yellow, amorphous solid from the CH2Cl2 extract 
of M. barteri. The HRESIMS of 1 (Fig. S12, Supporting Information) showed the protonated 
molecule [M+H]+ at m/z 467.2788, corresponding to C29H39O5 (calcd 467.2792) and indicating 
11 double-bond equivalents, which is consistent with a stilbene skeleton, with two additional 
degrees of unsaturation. The 1H NMR spectrum of 1 (Fig. S2, Supporting Information) of 1 in 
CD3OD revealed signals for two trans olefinic protons (δH 6.82, d (16.0), H-1'; δH 6.67, d 
(16.0), H-2'). In addition, the UV spectrum of 1 (Fig. S13, Supporting Information) showed 
maximum absorption at 332 nm confirming that the basic skeleton was identical to that of 
stilbene such as vedelianin [6] and resveratrol [23]. The 13C NMR data of 1 (Table 1) revealed 
29 signals comprising eleven quaternary, eight methine, five methylene and five methyl carbon 
atoms based on the analysis of the DEPTQ and HSQC spectra (Fig. S5-S7, Supporting 
Information). Further analysis of the 1H NMR spectrum of 1 (Fig. S2, Supporting Information) 
showed a symmetrically substituted AA' benzene ring system (ring A) (δH 6.45, 2H, s, H-4'and 
H-8'). Two of the five methyl singlets present in the 1H NMR spectrum of 1 showed HMBC 
correlations characteristic of a prenyl side chain. The HMBC correlations from H-4'' (δH 1.68, 
s) to the sp2 carbons at C-2'' (δC 123.2) and C-3'' (δC 129.7), the C-5'' (δC 16.5) methyl group as 
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well as COSY correlation between H-1'' (δH 3.30, d (7.9)) and H-2'' (δH 5.26, dd (6.4, 1.4)) 
confirmed the presence of a prenyl moiety. In the HMBC spectrum of 1 (Fig. S9, Supporting 
Information), the methylene signal at δH 3.30 (H-1'') showed correlation with C-5', C-7' (δC 
155.8) and C-6' (δC 114.4), indicating that the prenyl chain was linked to the ring A at position 
C-6'. The 1H NMR spectrum of 1 (Fig. S2, Supporting Information) revealed that the second 
benzene ring (ring B) of the stilbene was an AB benzene ring system (δH 6.84, d (2.2), H-3; δH 
6.71, d (2.2), H-5). The signal at δH 5.38 (H-8, dd (7.8, 1.5)) showed correlation in the HMBC 
spectrum with the methylene carbon C-7 (δC 27.7), the methyl carbon C-10 (δC 14.7) and the 
methylene carbon C-11 (δC 39.9), indicating that these signals were associated with the inner 
prenyl unit. The signal at δH 3.34 (H-7, partially obscured by the solvent) showed HMBC 
correlations with C-1 (δC 142.8), C-5 (δC 119.2), C-6 (δC 128.2), C-8 (δC 122.8) and C-9 (δC 
135.3) indicating that the inner geranyl group was attached to ring B at position C-6. 
Assignment of the E configuration at the C-8:C-9 double bond was deduced from the nuclear 
Overhauser effect (NOE) correlation between H-10 and H-7 in the 2D NOESY spectrum (Fig. 
S11, Supporting Information). Quaternary and phenolic carbons were unambiguously assigned 
by long-range HMBC correlations (H-2' to C-4, H-3 to C-1 and C-2, H-7 to C-6, H-4'/8' to C-
6', H-1' to C-3', H-1'' to C-5'/7') (Fig. 1). The 13C NMR signal at 70.1 ppm (C-14) indicated that 
1 bears an aliphatic hydroxy group. The HMBC correlations of the signal at δH 1.46 (H-13, m) 
with C-11, C-12, and C-14 and the COSY correlations between H-11 (δH 2.08, t) and H-12 (δH 
1.54, m); and H-12 and H-13 (δH 1.46, m) indicated the linkage of the hydroxy chain with the 
inner prenyl unit. The final methyl signals at δH1.19 (6H) showed HMBC correlations to the 
tertiary alcohol at C-14, as well as to the methylene carbon C-13 (δC 42.9), further confirming 
the structure of this portion of the molecule. In addition, the symmetrical methyl carbons C-15 
and C-16 were linked to the tertiary alcohol at C-14. On the basis of the foregoing evidences, 
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the structure of macabartebene A (1) was elucidated as 5-((E)-3,5-dihydroxy-4-(3-methylbut-
2-en-1-yl)styryl)-3-((E)-7-hydroxy-3,7-dimethyloct-2-en-1-yl)benzene-1,2-diol. 
     Macabartebene B (2) was obtained as an amorphous pale yellow solid. From the HRESIMS 
analysis (Fig. S25, Supporting Information), it was determined to have the same protonated 
molecule ([M+H]+ at m/z 467.2789) and molecular formula (C29H39O5) as 1. The UV spectrum 
of 2 (Fig. S26, Supporting Information) revealed maximum wavelength of absorption at 330 
nm suggesting that the basic stilbene skeleton present in 1 was also available in 2. The 1H NMR 
data of 2 (Table 1) was similar to 1, showing two trans-olefinic protons linked to aromatic 
rings (δH 6.83, d (16.2), H-1'; δH 6.69, d (16.2), H-2'), a symmetrically substituted AA' benzene 
ring system (ring A) (δH 6.47, 2H, s, H-4', H-8') and an AB benzene ring system (δH 6.86, d 
(1.9), H-3; δH 6.72, d (1.9), H-5). However, the prenyl unit that was attached to ring A of 1 was 
absent in 2. Instead, it was observed from the 1H- and 13C- NMR data (Table 1) that the double 
bond of the prenyl unit in 1 was hydrated in 2. This was confirmed by the presence of an 
aliphatic hydroxy group (C-3'', δC 70.5) in 2 that showed HMBC correlation with H-1'' (δH 2.69, 
m), H-2'' (δH 1.71, t (7.1)), H-4'' (δH 1.28, s) and H-5'' (δH 1.28, s) (Fig. 1). The remaining signals 
in the 1H NMR spectrum of 2 (Fig. S15-S17, Supporting Information) included two olefinic 
triplets [δH 5.38, d (7.2, 1.2), H-8; δH 5.16, dd (6.7, 1.4), H-13], three methylene multiplets (δH 
3.34, H-7; δH 2.09, H-11; δH 2.16, H-12) and three methyl singlets (δH 1.77, H-10; δH 1.63, H-
15; δH 1.68, H-16). Overall, these signals matched very closely those published for the geranyl 
group of known stilbenes isolated from M. schweinfurthii. [9,12]. Furthermore, HMBC 
resonances from H-8 to C-7 (δC 27.6), C-10 (δC 14.8) and C-11 (δC 39.5) and from H-13 to C-
11, C-15 (δC 16.5), C-16 (δC 24.5) provided further evidence for the presence of the geranyl 
moiety (Fig. 1). Assignment of the E configuration at the C-8:C-9 double bond was deduced 
from the nuclear Overhauser effect (NOE) correlation between H-10 and H-7 in the 2D 
NOESY spectrum (Fig. S24, Supporting Information). Quaternary and phenolic carbons were 
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definitively assigned by long-range HMBC correlations as seen in 1 above. In the HMBC 
spectrum of 2 (Fig. S21-S23, Supporting Information), the methylene signal at δH 3.34 (H-7) 
showed correlation with C-1 (δC 142.8), C-5 (δC 119.2), C-6 (δC 128.2), C-8 (δC 122.7) and C-
9 (δC 135.2), indicating that the geranyl chain was attached to ring B at position C-6. On the 
basis of these data, the structure of macabartebene B (2) was elucidated as 5-((E)-3,5-
dihydroxy-4-(3-hydroxy-3-methylbutyl)styryl)-3-((E)-3,7-dimethylocta-2,6-dien-1-
yl)benzene-1,2-diol.  
     Macabartebene C (3) was obtained as an amorphous brown solid. A molecular formula of 
C29H38O5 was deduced from the HRESIMS of 3 (Fig. S38, Supporting Information), which 
presented the protonated molecule at m/z 467.2788 [M+H]+ (calcd 467.2792). The molecular 
formula of 3 was similar to that of 1 and 2 and also suggested 11 degrees of unsaturation. The 
13C NMR data of 3 (Table 1) revealed 29 signals comprising eleven quaternary, eight methine, 
five methylene and five methyl carbon atoms based on the analysis of the DEPTQ and HSQC 
spectra (Fig. S32-S34, Supporting Information). The 1H NMR spectrum of 3 (Fig. S28-30, 
Supporting Information) revealed the presence of two trans-olefinic protons attached to an 
aromatic ring (δH 6.84, d (16.3), H-1'; δH 6.71, d (16.3), H-2'), which confirms the stilbene basic 
skeleton of 3. This was corroborated by the UV spectrum of 3 (Fig. S39, Supporting 
Information) that showed maximum absorption at 332 nm, which is typical of stilbenes. Further 
examination of the 1H- and 13C- HMR spectra (Fig. S28-S31, Supporting Information) revealed 
that the stilbene was made up of two AB benzene ring systems; ring A (δH 6.46, d (1.4), H-4'; 
δH 6.39, d (1.4), H-8') and ring B (δH 6.86, d (1.9), H-3; δH 6.73, d (1.9), H-5). Key HMBC and 
COSY correlations and the presence of an aliphatic hydroxy group (C-3'', δC 74.8) in 3 revealed 
that the hydrated prenyl moiety present in 2 was also present in 3 (Fig. 1). However, unlike 2 
where the moiety attached to ring A at position C-6', the hydrated prenyl group was linked to 
ring A of 3 at position C-7'. This position further supported the lack of symmetry in ring A of 
14 
 
3 that was observed in ring A of 2. Careful examination of the remaining signals on the 1H- 
and 13C- NMR spectra (Fig. S28-S32, Supporting Information) together with HMBC and 
COSY spectra (Fig. S33-S37, Supporting Information) confirmed the presence of a geranyl 
moiety, which was linked to ring B at position C-6, like what was observed in 2. The location 
of the hydrated prenyl group turned out to be the only difference between 2 and 3. According 
to these spectral data, the structure of macabartebene C (3) was elucidated as 5-((E)-3,4-
dihydroxy-5-(3-hydroxy-3-methylbutyl)styryl)-3-((E)-3,7-dimethylocta-2,6-dien-1-
yl)benzene-1,2-diol. 
     The known compounds vedelianin (4) [6], schweinfurthin G (5) [24], 8-prenylkaempferol 
(6) [25], mappain (7) [26], broussoflavonol F (8) [27], and isomacarangin (9) [11] were 
determined by the comparison of their spectroscopic data with those reported in the literature 
(Fig. S43; Supporting Information). All the compounds were isolated from M. barteri for the 
first time. 
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Table 1. 1H (600 MHz, CD3OD) and 
13C (150 MHz, CD3OD) NMR data of compounds 1−3  
Position 1  2  3 
 1H (J in Hz) 
13C, mult.   1H (J in Hz) 
13C, mult.  1H (J in Hz) 
13C, mult. 
1  142.8, C   142.8, C   144.3, C 
2  144.6, C   144.7, C   146.1, C 
3 6.84, d (2.2) 109.6, CH  6.86, d (1.9) 109.6, CH  6.86, d (1.9) 111.0, CH 
4  129.0, C   129.0, C   129.6, C 
5 6.71, d (2.2) 119.2, CH  6.72, d (1.9) 119.2, CH  6.73, d (1.9) 120.7, CH 
6  128.2, C   128.2, C   129.2, C 
7 3.34, obsb 27.7, CH2  3.34, obs
b 27.6, CH2  3.34, obs
b 29.0, CH2 
8 5.38, dd (7.8, 1.5) 122.8, CH  5.38, dd (7.2, 1.2) 122.7, CH  5.38, dd (7.6, 1.2) 124.2, CH 
9  135.3, C   135.2, C   136.6, C 
10 1.76, s 14.7, CH3  1.77, s 14.8, CH3  1.76, s 16.2, CH3 
11 2.08, dd (7.4, 1.4) 39.9, CH2  2.09, m 39.5, CH2  2.09, m 40.5, CH2 
12 1.54, m 22.3, CH2  2.16, m 26.4, CH2  2.16, m 27.8, CH2 
13 1.46, m 42.9, CH2  5.16, dd (6.7, 1,4) 124.0, CH  5.16, dd (7.0, 1,4) 125.4, CH 
14  70.1, C   130.9, C   132.2, C 
15 1.19, s 27.8, CH3  1.63, s 16.5, CH3  1.63, s 17.8, CH3 
16 1.19, s 27.8, CH3  1.68, s 24.5, CH3  1.68, s 25.9, CH3 
1' 6.82, d (16.0) 127.6, CH  6.83, d (16.2) 127.6, CH  6.84, d (16.3) 129.3, CH 
2' 6.67, d (16.0) 125.6, CH  6.69, d (16.2) 125.5, CH  6.71, d (16.3) 126.8, CH 
3'  136.3, C   136.3, C   138.3, C 
4' 6.45, s 104.3, CH  6.47, s 103.1, CH  6.46, d (1.4) 104.5, CH 
5'  155.8, C   155.9, C   156.2, C 
6'  114.4, C   115.3, C   156.8, C 
7'  155.8, C   155.9, C   109.3, C 
8' 6.45, s 104.3, CH  6.47, s 103.1, CH  6.39, d (1.4) 107.8, CH 
1'' 3.30, d (7.9) 21.9, CH2  2.69, m 18.0, CH2  2.66, m 17.8, CH2 
2'' 5.26, dd (6.4, 1.4) 123.2, CH  1.71, t (7.1) 42.1, CH2  1.81, t (7.1) 33.5, CH2 
3''  129.7, C   70.5, C   74.8, C 
4'' 1.68, s 24.6, CH3  1.28, s 25.5, CH3  1.33, s 26.9, CH3 
5'' 1.78, s 16.5, CH3  1.28, s 27.7, CH3  1.33, s 26.9, CH 
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     The cytotoxicity of the extracts, fractions and all isolated compounds was determined, using 
the MTT assay, against MCF7 (human breast adenocarcinoma), HeLa (human cervix 
adenocarcinoma), A549 (human lung adenocarcinoma) and PC3 (human prostate carcinoma) 
cell lines. These cell lines were chosen for this study because of the high prevalence of these 
cancers and the need to develop effective and safe chemotherapeutic agents. As an illustration, 
the breast and cervical cancers are the commonest form of cancer in women, while the prostate 
cancer is the most frequently diagnosed cancer type in men. In addition, lung cancer was the 
commonest cause of cancer mortality globally in 2015, accounting for 18.2% (1.7 million 
deaths) of the total cancer mortality [28]. Among the extracts, the CH2Cl2 extract displayed the 
highest cytotoxicity with its greatest effect on the breast carcinoma (IC50  = 2.5 µg/mL) and the 
lowest effect on the prostate carcinoma cells (IC50 = 3.9 µg/mL) (Table S1; Supporting 
Information). This fraction accounted for the antiproliferative activities of this extract and was 
therefore subjected to bioassay-guided fractionation. Among the seven sub-fractions (MBF1 – 
MBF7) obtained from solid phase extraction (SPE) fractionation, only MBF4 and MBF5 
retained the antiproliferative activity of the extract as indicated by their low IC50 value (Table 
S1; Supporting Information). Chromatographic separation of MBF4 and MBF5 using reversed-
phase preparative HPLC led to the isolation of compounds 1-9. Since stilbenes and flavonoids 
have been reported to exhibit moderate or strong antiproliferative activities [29,30], the 
cytotoxicity of compounds 1-9 were evaluated against four human cancer cell lines, with 
vinblastine as the positive control and DMSO vehicle as the negative control. The results of 
the cytotoxicity of compounds 1-9 are shown in Table 2.  
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Table 2: Antiproliferative Effects of compounds 1-9 Isolated from the Leaves of Macaranga 
barteri against Four Human Cancer Cell Linesa and the Normal Human Prostate Cell Line 
 IC50 (µM)
b  
Compound MCF7 A549 PC3 HeLa PNT2  
1 0.68 ± 0.01 0.79 ± 0.01 0.66 ± 0.01 0.60± 0.01 9.08 ± 0.11 
2 0.71 ± 0.02 0.74 ± 0.01 0.69 ± 0.01 0.72 ± 0.01 11.12 ± 0.11 
3 1.73 ± 0.01 1.81 ± 0.00 1.61 ± 0.01 1.67 ± 0.01 10.81 ± 0.17 
4 0.32 ± 0.03 0.54 ± 0.02 0.39 ± 0.01 0.51 ± 0.01 3.76 ± 0.12 
5 0.95 ± 0.02 1.10 ± 0.09 0.91 ± 0.01 1.18 ± 0.01 13.61 ± 0.41 
6 6.22 ± 0.13 6.61 ± 0.21 6.53 ± 0.11 6.88 ± 0.16 27.06 ± 0.06 
7 0.71 ± 0.02 0.81 ± 0.02 0.77 ± 0.01 0.71 ± 0.01 12.94 ± 0.06 
8 4.13 ± 0.00 3.83 ± 0.01 3.99 ± 0.01 4.10 ± 0.01 22.31 ± 0.13 
9 8.43 ± 0.26 8.72 ± 0.21 8.5 ± 0.31 8.49 ± 0.21 25.11 ± 0.43 
Vinblastine 0.02 ± 0.01 0.03 ± 0.01 0.03 ± 0.01 0.02 ± 0.01 0.06 ± 0.01 
aMCF7, human breast adenocarcinoma; A549, human lung carcinoma; PC3, human prostate 
adenocarcinoma; HeLa = human cervix adenocarcinoma; PNT2 = normal human immortalised 
prostate cell line. bMTT method, with the cells incubated with the test compounds for 72 h 
(means ± SEM, n = 3). 
 
     All the test compounds displayed concentration-dependent activity across the four human 
carcinoma cell lines (Supplementary Fig. S41 and S43), although with varying degrees of 
potency as revealed by their IC50 values (Table 2). The isolated compounds could be classified 
into two classes; stilbenes (1-5, 7) and flavonols (6, 8-9). It was observed that the stilbenes 
showed potent cytotoxicity, while the flavonols displayed moderate cytotoxicity against the 
cancer cell line under investigation. Amongst the stilbenes, vedelianin (4) displayed the highest 
cytotoxicity. Comparing the cytotoxicities of vedelianin with those of schweinfurthin G (5) 
across the panel of carcinoma cells under investigation (Table 3), it was observed that 
vedelianin was almost thrice as potent as schweinfurthin G, suggesting that the C-3 hydroxy 
group enhances the activity of vedelianin. A previous studies comparing the antiproliferative 
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activities of vedelianin with schweinfurthin G on the A2780 human ovarian cancer cell line, a 
similar result was observed [24]. It is interesting to mention that vedelianin (4) and 
schweinfurthin G (5) are structurally related to cyclocannabigerols A and B, cyclized 
isoprenoid cannabinoids isolated Cannabis that demonstrated remarkable modulation of the 
transient receptor potential (TRP) proteins  [31]. Macabartebenes A (1) and B (2) which have 
hydrated prenyl side chain, compared to mappain (7), have similar IC50 values with mappain, 
across the cell line under investigation. This suggest that hydration of the geranyl side-chain of 
mappain does not markedly affect its cytotoxicity. This is in line with an earlier observation by 
Beutler et al., who reported that schweinfurthin D, containing a hydrated geranyl moiety, was 
found to be equipotent with schweinfurthin B against SF295 (brain carcinoma cells) and A549 
(lung carcinoma cells) [10]. However, the symmetrically substituted AA' benzene ring system 
of ring A seems to be expedient for the cytotoxicity of both macabartebenes A and B, as 
macabartebene B (3) which has a hydrated prenyl side-chain at position C-7' had a lower 
cytotoxicity, compared to its two other structural isomers.  
     Vedelianin, mappain and the schweinfurthin class of stilbenes have been widely 
investigated for their antiproliferative activity on various cancer cell lines, especially by several 
researchers at the National Cancer Institute (NCI) [10,12,24,9,26]. Also, several studies have 
been undertaken to evaluate the biological activities of many schweinfurthin analogues in order 
to develop the structure-activity relationships which will guide in the design of drug leads for 
their putative molecular target [32,33]. In particular, vedelianin was reported to be the most 
potent antiproliferative agents amongst group of naturally occurring stilbenes with IC50 of 130 
nM against A2780 cells, mean GI50 of 78 nM in the 60 cell line assay of the NCI and GI50 value 
below 1 nM in several other individual cell lines [24]. This intriguing antiproliferative activity 
of vedelianin (4) has necessitated the recent total synthesis of vedelianin in order to further 
examine its biological activity in vivo [34]. This is the first report of the isolation of stilbenes 
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from M. barteri although vedelianin, mappain and schweinfurthin G have been isolated from 
other species of the Macaranga genus. 
     In the present study, it was observed that broussoflavonol F (8) displayed the highest 
cytotoxicity (IC50 value of 3.83 – 4.13 μM) across the cell lines amongst the flavonols. It was 
also observed that 8-prenylkaempferol (6) that lacks the prenyl group present in position C-3 
of broussoflavonol had a lower cytotoxicity (IC50 value of 6.22 – 6.88 μM) than 
broussoflavonol. Isomacarangin (9) contained a geranyl group in position C-8, unlike the 
prenyl moiety present in 8-prenylkaempferol. This led to a slight reduction in antiproliferative 
activities (IC50 value 8.43 – 8.72 μM) against the carcinoma cell lines. To the best of the 
knowledge in available literature, this is the first report of the isolation of these three flavonoids 
from M. barteri and their cytotoxicity. The Macaranga genus has been reported to be rich in 
cytotoxic flavonoids, especially prenylated and geranylated flavonoids [3,35,36]. Potent 
cytotoxic flavonoids from this genus include malaysianone A, 6-prenyl-3′-methoxyeriodictyol, 
nymphaeols B-C from M. trilobal; kurzphenols B-C from M. kurzii; denticulatins C-E from M. 
denticulata; and macarindicins A–C from M. indica [36,37,35,38]. 
     The ultimate goal of cancer chemotherapy is the ability of anticancer agents to differentiate 
between cancerous and normal human cell line. Chemotherapeutic agents are expected to 
display selective toxicity as this is needful to overcome noxious side effects associated with 
usage. To measure the selectivity index (SI) of the isolated compounds used in this study, the 
normal human prostate cells (PNT2) was used. Vinblastine, the positive control, had a SI value 
ranging from 1.00 to 1.76 across the cancer cell lines, indicating that the drug cannot 
sufficiently differentiate between normal and cancer cells. This lack of cancer cell specificity 
of vinblastine was also reported in previous work [22,39]. It is interesting to note that apart 
from 9, the cytotoxicities of these compounds were significantly lower towards the normal 
human cell line compared to the cancer cells (Table 3). The stilbenes, which displayed potent 
20 
 
cytotoxicities against the cell lines, also showed better SI, with mappain (7) exhibiting 
approximately 15- to 18- fold higher IC50 value against the carcinoma cell lines compared to 
PNT2. On the other hand, the flavonols showed lower SI across the cell lines under 
investigation. In fact, 9 displayed SI value that is similar to that of vinblastine, indicating that 
it is only two to three times more cytotoxic to the cancer cells than the PNT2 cells.  
 
Table 3. The Selectivity Index (SI) of Compounds 1-9 and Vinblastine (VBN) 
 
Compound MCF7 A549 PC3 HeLa 
1 13.35 11.49 13.75 15.13 
2 15.66 15.02 16.11 15.44 
3 6.24 5.97 6.71 6.47 
4 11.75 6.96 9.64 7.37 
5 14.32 12.37 14.95 11.53 
6 4.35 4.09 4.14 3.93 
7 18.22 15.97 16.80 18.22 
8 5.40 5.82 5.59 5.44 
9 2.97 2.87 2.95 2.95 
Vinblastine 1.60 1.00 1.32 1.76 
MCF7, human breast cancer cells; A549, Human lung carcinoma cells; PC3, human prostate 
carcinoma cells; HeLa, human cervix carcinoma cells. SI is the ratio of the IC50 values of the 
compound on PNT2 cells to those in the cancer cell lines. 
 
     Recent studies have revealed the promising antibacterial, antifungal, antiprotozoal and 
antiviral activities of the extract of the leaves of M. barteri, and stated that at the tested doses, 
the extract could be considered relatively safe and non-toxic [40-42]. The antiproliferative 
activity of the DCM fraction of M. barteri reported herein and the abundance of cytotoxic 
compounds in this plant may provide evidence for its use in folklore medicine for the treatment 
of various cancers. 
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3. Conclusion 
     To summarise our findings, the phytochemical investigations of the leaves of Macaranga 
barteri led to the isolation and structure elucidation of six stilbenes (1-5, 7) including three 
previously unreported ones (1-3) and three flavonols (6, 8-9). Their cytotoxicity against human 
breast adenocarcinoma (MCF7), human cervix adenocarcinoma (HeLa), human lung 
adenocarcinoma (A549) and human prostate adenocarcinoma (PC3) were evaluated. Overall, 
the stilbenes possess more cytotoxic activity than the flavonols with vedelianin (4) being the 
most cytotoxic across the panel of cancer cell lines amongst the compounds, while 
macabartebene A (1) was the most potent of the new compounds. The antiproliferative activity 
of the leaves of M. barteri reported in this study may provide evidence for its use in folklore 
medicine for the treatment of various cancers. 
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